journal article·2024-07-31

NIR-II Light-Actuated Nanomotors for Enhanced Photoimmunotherapy Toward Hepatocellular Carcinoma

Yichi Chen, Wenxin Xu, Huimin Tian, Junbin Gao, Yicheng Ye, Hanfeng Qin, Hong Wang, Yanzhen Song, Chuxiao Shao, Fei Peng, Yingfeng Tu

ACS Applied Materials & Interfaces· Volume 16· Issue 30
Publisher page

Abstract

Light-propelled nanomotors, which can convert external light into mechanical motion, have shown considerable potential in the construction of a new generation of drug delivery systems. However, the therapeutic efficacy of light-driven nanomotors is always unsatisfactory due to the limited penetration depth of near-infrared-I (NIR-I) light and the inherent biocompatibility of the motor itself. Herein, an asymmetric nanomotor (Pd@ZIF-8/R848@M JNMs) with efficient motion capability is successfully constructed for enhanced photoimmunotherapy toward hepatocellular carcinoma. Under near-infrared-II (NIR-II) irradiation, Pd@ZIF-8/R848@M JNMs convert light energy into heat energy, exhibiting self-thermophoretic locomotion to penetrate deeper into tumor tissues to achieve photothermal therapy. At the same time, functionalized with an immune-activated agent Resiquimod (R848), our nanomotors could convert a "cold tumor" into a "hot tumor", transforming the immunosuppressive microenvironment into an immune-activated state, thus achieving immunotherapy. Dual photoimmunotherapy of the as-developed NIR-II light-driven Pd@ZIF-8/R848@M JNMs demonstrates considerable tumor inhibition effects, offering a promising therapeutic approach in the field of anticancer therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Micro and Nano Robotics · Nanoplatforms for cancer theranostics · Phagocytosis and Immune Regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China

Department of Ultrasound, Harbin Medical University Cancer Hospital, Harbin 150081, China

Key Laboratory of Joint Diagnosis and Treatment of Chronic Liver Disease and Liver Cancer of Lishui, Central Laboratory of Lishui People’s Hospital, The Sixth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang 323000, China

School of Materials Science and Engineering, Sun Yat-Sen University, Guangzhou 510275, China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China · Key Research and Development Project of Lishui

References (45)

Show source-provided references
1. 10.1056/NEJMra171326310.1056/NEJMra1713263 ↗
2. 10.1038/nrdp.2016.1810.1038/nrdp.2016.18 ↗
3. 10.3322/caac.2149210.3322/caac.21492 ↗
4. 10.1038/nrd198410.1038/nrd1984 ↗
5. Uramoto H. · Transl. Lung Cancer Res. · 2014 · 3 · 242
6. 10.1016/j.copbio.2016.02.00110.1016/j.copbio.2016.02.001 ↗
7. 10.1038/ncponc010110.1038/ncponc0101 ↗
8. 10.1001/jamaoncol.2018.392310.1001/jamaoncol.2018.3923 ↗
9. 10.1016/j.semcancer.2019.12.01910.1016/j.semcancer.2019.12.019 ↗
10. 10.1021/nn506202910.1021/nn5062029 ↗
11. 10.1038/nrc82110.1038/nrc821 ↗
12. 10.1182/blood-2011-07-36582510.1182/blood-2011-07-365825 ↗
13. 10.1097/CJI.0b013e31818ac2f710.1097/CJI.0b013e31818ac2f7 ↗
14. 10.1016/j.ejca.2006.01.00310.1016/j.ejca.2006.01.003 ↗
15. 10.1016/j.ctrv.2018.08.01010.1016/j.ctrv.2018.08.010 ↗
16. 10.1016/j.cell.2010.03.01410.1016/j.cell.2010.03.014 ↗
17. 10.1002/JLB.3RU1018-378RR10.1002/JLB.3RU1018-378RR ↗
18. 10.1021/acsnano.9b0299310.1021/acsnano.9b02993 ↗
19. 10.1016/j.biomaterials.2019.11951510.1016/j.biomaterials.2019.119515 ↗
20. 10.1002/smll.20200354310.1002/smll.202003543 ↗
21. 10.1038/nri.2016.15310.1038/nri.2016.153 ↗
22. 10.1002/smll.20200021410.1002/smll.202000214 ↗
23. 10.7150/thno.1982610.7150/thno.19826 ↗
24. 10.1021/acs.nanolett.7b0318610.1021/acs.nanolett.7b03186 ↗
25. 10.1002/adma.20190296010.1002/adma.201902960 ↗
26. 10.1021/acsnano.9b0721210.1021/acsnano.9b07212 ↗
27. 10.1007/978-3-030-62658-7_110.1007/978-3-030-62658-7_1 ↗
28. 10.1038/nature1203410.1038/nature12034 ↗
29. 10.1038/nrclinonc.2016.21710.1038/nrclinonc.2016.217 ↗
30. 10.1038/s41467-019-11269-810.1038/s41467-019-11269-8 ↗
31. 10.1016/j.jconrel.2014.12.01810.1016/j.jconrel.2014.12.018 ↗
32. 10.1038/s41571-019-0308-z10.1038/s41571-019-0308-z ↗
33. 10.1021/acsnano.1c0736310.1021/acsnano.1c07363 ↗
34. 10.1021/acs.accounts.8b0024910.1021/acs.accounts.8b00249 ↗
35. 10.1021/acsnano.0c0840410.1021/acsnano.0c08404 ↗
36. 10.1002/smll.20190670110.1002/smll.201906701 ↗
37. 10.1016/j.ejphar.2022.17501110.1016/j.ejphar.2022.175011 ↗
38. 10.1002/adhm.20200121210.1002/adhm.202001212 ↗
39. 10.1021/acs.langmuir.7b0112310.1021/acs.langmuir.7b01123 ↗
40. 10.1038/s41467-021-22279-w10.1038/s41467-021-22279-w ↗
41. 10.1002/smll.20160196510.1002/smll.201601965 ↗
42. 10.1016/j.biomaterials.2019.01.04210.1016/j.biomaterials.2019.01.042 ↗
43. 10.1039/D3NR03760F10.1039/D3NR03760F ↗
44. 10.1103/PhysRevLett.99.04810210.1103/PhysRevLett.99.048102 ↗
45. 10.1126/sciadv.aay975110.1126/sciadv.aay9751 ↗